References
- Wang DS, Louie JD, Sze DY. Intra-arterial therapies for metastatic colorectal cancer. Semin Intervent Radiol 2013;30:12-20 https://doi.org/10.1055/s-0033-1333649
- Gruber-Rouh T, Naguib NN, Eichler K, Ackermann H, Zangos S, Trojan J, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer 2014;134:1225-1231 https://doi.org/10.1002/ijc.28443
- Leichman CG, Jacobson JR, Modiano M, Daniels JR, Zalupski MM, Doroshow JH, et al. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial. Cancer 1999;86:775-781 https://doi.org/10.1002/(SICI)1097-0142(19990901)86:5<775::AID-CNCR12>3.0.CO;2-M
- Wilcox RA, Djulbegovic B, Moffitt HL, Guyatt GH, Montori VM. Randomized trials in oncology stopped early for benefit. J Clin Oncol 2008;26:18-19 https://doi.org/10.1200/JCO.2007.13.6259
- Konopke R, Roth J, Volk A, Pistorius S, Folprecht G, Zophel K, et al. Colorectal liver metastases: an update on palliative treatment options. J Gastrointestin Liver Dis 2012;21:83-91
- Whisenant J, Venook A. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer. Oncology (Williston Park) 2004;18:762-768; discussion 769-773
- Kennedy AS, Salem R. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 2010;16:163-175 https://doi.org/10.1097/PPO.0b013e3181d7e8cf
- Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009;250:466-473 https://doi.org/10.1148/radiol.2502072222
- Li Z, Bonekamp S, Halappa VG, Corona-Villalobos CP, Pawlik T, Bhagat N, et al. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization. Radiology 2012;264:97-109 https://doi.org/10.1148/radiol.12112161
- Forner A, Ayuso C, Varela M, Rimola J, Hessheimer AJ, de Lope CR, et al. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 2009;115:616-623 https://doi.org/10.1002/cncr.24050
- Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390 https://doi.org/10.1056/NEJMoa0708857
- Gowdra Halappa V, Corona-Villalobos CP, Bonekamp S, Li Z, Reyes D, Cosgrove D, et al. Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. Radiology 2013;266:502-513 https://doi.org/10.1148/radiol.12120495
- Anzidei M, Napoli A, Zaccagna F, Cartocci G, Saba L, Menichini G, et al. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging. J Comput Assist Tomogr 2011;35:690-696 https://doi.org/10.1097/RCT.0b013e318230d905
- Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol 2012;47:11-17 https://doi.org/10.1097/RLI.0b013e3182199bb5
- Yang L, Zhang XM, Zhou XP, Tang W, Guan YS, Zhai ZH, et al. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization. J Vasc Interv Radiol 2010;21:1841-1846 https://doi.org/10.1016/j.jvir.2010.08.015
- Vogl TJ, Gruber T, Balzer JO, Eichler K, Hammerstingl R, Zangos S. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 2009;250:281-289 https://doi.org/10.1148/radiol.2501080295
- Wang X, Xue HD, Jin ZY, Su BY, Li Z, Sun H, et al. Quantitative hepatic CT perfusion measurement: comparison of Couinaud's hepatic segments with dual-source 128-slice CT. Eur J Radiol 2013;82:220-226 https://doi.org/10.1016/j.ejrad.2012.09.015
- Carr BI, Kondragunta V, Buch SC, Branch RA. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer 2010;116:1305-1314 https://doi.org/10.1002/cncr.24884
- Islam R, Chyou PH, Burmester JK. Modeling efficacy of bevacizumab treatment for metastatic colon cancer. J Cancer 2013;4:330-335 https://doi.org/10.7150/jca.6083
- Morsbach F, Sah BR, Spring L, Puippe G, Gordic S, Seifert B, et al. Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques. Eur Radiol 2014;24:1455-1465 https://doi.org/10.1007/s00330-014-3180-3
- Reiner CS, Morsbach F, Sah BR, Puippe G, Schaefer N, Pfammatter T, et al. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. J Vasc Interv Radiol 2014;25:747-759 https://doi.org/10.1016/j.jvir.2014.01.025
- Morsbach F, Pfammatter T, Reiner CS, Fischer MA, Sah BR, Winklhofer S, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Invest Radiol 2013;48:787-794 https://doi.org/10.1097/RLI.0b013e31829810f7
- Singh J, Sharma S, Aggarwal N, Sood RG, Sood S, Sidhu R. Role of perfusion CT differentiating hemangiomas from malignant hepatic lesions. J Clin Imaging Sci 2014;4:10 https://doi.org/10.4103/2156-7514.127959
- Kruskal JB, Kane RA. Pathophysiology of hepatic perfusion changes in livers containing small or occult metastases. Radiology 1998;209:291-292
- Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I. In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 1998;71:276-281 https://doi.org/10.1259/bjr.71.843.9616236
- Choi SH, Chung JW, Kim HC, Baek JH, Park CM, Jun S, et al. The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model. Invest Radiol 2010;45:427-436
- Ng CS, Chandler AG, Wei W, Herron DH, Anderson EF, Kurzrock R, et al. Reproducibility of CT perfusion parameters in liver tumors and normal liver. Radiology 2011;260:762-770 https://doi.org/10.1148/radiol.11110331
- Ippolito D, Sironi S, Pozzi M, Antolini L, Invernizzi F, Ratti L, et al. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization. Eur J Radiol 2010;73:148-152 https://doi.org/10.1016/j.ejrad.2008.10.014
- Ghanaati H, Mohammadzadeh V, Mohammadzadeh A, Firouznia K, Mohammadzadeh M, Motevali M, et al. Efficacy of transarterial chemoembolization on lesion reduction in colorectal liver metastases. Acta Med Iran 2012;50:535-540
- Thng CH, Koh TS, Collins DJ, Koh DM. Perfusion magnetic resonance imaging of the liver. World J Gastroenterol 2010;16:1598-1609 https://doi.org/10.3748/wjg.v16.i13.1598
- Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology 2007;243:736-743 https://doi.org/10.1148/radiol.2433052020
- Jiang ZX, Peng WJ, Li WT, Tang F, Liu SY, Qu XD, et al. Effect of b value on monitoring therapeutic response by diffusion-weighted imaging. World J Gastroenterol 2008;14:5893-5899 https://doi.org/10.3748/wjg.14.5893
- Gillmore R, Stuart S, Kirkwood A, Hameeduddin A, Woodward N, Burroughs AK, et al. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 2011;55:1309-1316 https://doi.org/10.1016/j.jhep.2011.03.007
- Shim JH, Lee HC, Kim SO, Shin YM, Kim KM, Lim YS, et al. Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models. Radiology 2012;262:708-718 https://doi.org/10.1148/radiol.11110282
- Yeo DM, Choi JI, Lee YJ, Park MY, Chun HJ, Lee HG. Comparison of RECIST, mRECIST, and choi criteria for early response evaluation of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads. J Comput Assist Tomogr 2014;38:391-397 https://doi.org/10.1097/RCT.0000000000000070
Cited by
- Value or waste: Perfusion imaging following radiofrequency ablation - early experience vol.61, pp.2, 2015, https://doi.org/10.3233/ch-152000
- Early Response of Hepatocellular Carcinoma to Chemoembolization: Volume Computed Tomography Liver Perfusion Imaging as a Short-Term Response Predictor vol.41, pp.2, 2017, https://doi.org/10.1097/rct.0000000000000511
- Evaluation of Multislice Spiral Computed Tomography Perfusion Imaging for the Efficacy of Preoperative Concurrent Chemoradiotherapy in Middle-Aged and Elderly Patients with Locally Advanced Gastric Ca vol.24, pp.None, 2015, https://doi.org/10.12659/msm.905143
- Perfusion Computer Tomography Assessment of the Effect of Angiotensin II On Blood Flow Distribution in Rabbits with Intrarenal VX2 Tumors vol.47, pp.1, 2015, https://doi.org/10.1159/000489752
- Investigation of the values of CT perfusion imaging and ultrasound elastography in the diagnosis of liver fibrosis vol.16, pp.2, 2015, https://doi.org/10.3892/etm.2018.6269
- Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer vol.20, pp.4, 2015, https://doi.org/10.3348/kjr.2018.0306
- Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology vol.20, pp.5, 2019, https://doi.org/10.3348/kjr.2018.0273
- A Systematic Review on the Role of the Perfusion Computed Tomography in Abdominal Cancer vol.19, pp.4, 2021, https://doi.org/10.1177/15593258211056199